Similar in size, shape and thickness to a postage stamp, PharmFilm is a truly unique drug delivery platform that represents a leap forward in how pharmaceutical products are developed and administered. PharmFilm benefits both patient and pharmaceutical provider by fostering a more convenient, precise and potentially safer means for delivering prescription drugs.

MonoSol Rx and PharmFilm Drug Delivery Technology

Latest News
April 7, 2016
U.S. Patent and Trademark Office Upholds the Validity of MonoSol Rx’s US Patent No. 8,765,167 in the Face of Multiple Inter Partes Review Challenges Brought by BioDelivery Sciences International, Inc. (BDSI)
April 4, 2016
Cynapsus Therapeutics and MonoSol Rx Announce Global IP Licensing Agreement
March 25, 2016
MonoSol Rx Successfully Completes Pre-IND Meeting with the FDA for PharmFilm® Tadalafil
PharmFilm Advantages

MonoSol Rx has cemented a leadership position in the transition of prescription drugs to film. Our patented PharmFilm® technology platform enables a wide range of pharmaceutical products to be delivered buccally, sublingually, enterally and through other mucosal surfaces for the improvement of healthcare for patients.

Partners and Licensing
Partnering with MonoSol Rx offers pharmaceutical companies the ability to introduce products that are highly differentiated from other dosage forms, both in performance and marketability, creating fresh, dynamic revenue-generating opportunities.